We are live on ! Find out more
ACHV icon

Achieve Life Sciences
ACHV

29 hedge funds and large institutions have $17.5M invested in Achieve Life Sciences in 2021 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

325% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 4

193% more capital inflows, than outflows

Capital inflows: $12.6M | Capital outflows: $4.28M

167% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 3

81% more funds holding

Funds holding: 16 → 29 (+13)

6.22% less ownership

Funds ownership: 27.82% → 21.6% (-6.2%)

Holders
29
Holders Change
+13
Holders Change %
+81.25%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
8
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Shay Capital
Shay Capital
New York
+$2.55M
2
Perkins Capital Management
Perkins Capital Management
Minnesota
+$1.25M
3
6CM
683 Capital Management
New York
+$1.19M
4
ACM
Altium Capital Management
New York
+$1.16M
5
Clearline Capital
Clearline Capital
New York
+$1.16M

Top Sellers

Rank Fund Capital Flow
1
Ikarian Capital
Ikarian Capital
Texas
-$3.29M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$448K
3
Boothbay Fund Management
Boothbay Fund Management
New York
-$387K
4
Citadel Advisors
Citadel Advisors
Florida
-$144K
5
Tower Research Capital (TRC)
Tower Research Capital (TRC)
New York
-$10.2K

ACHV Hedge Fund Activity: Q2 2021 in Review

29 of the 5,769 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q2 2021, worth a combined $17.5M — up 50% from $11.7M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new ACHV positions and 4 closed out — a net gain of 13 holders — while 8 added to existing stakes and 3 trimmed.

The largest buyer was Shay Capital, adding an estimated $2.55M. The largest seller was Ikarian Capital, exiting entirely with an estimated $3.29M sold.

  • 29 institutional investors held Achieve Life Sciences (ACHV) as of Q2 2021, up from 16 in Q1 2021.
  • Funds reported $17.5M of Achieve Life Sciences stock for Q2 2021, up 50% quarter-over-quarter.
  • 17 funds opened new Achieve Life Sciences positions in Q2 2021 and 4 closed out, a net change of +13 holders.
  • The largest Achieve Life Sciences buyer in Q2 2021 was Shay Capital, an estimated $2.55M added.
  • The largest Achieve Life Sciences seller in Q2 2021 was Ikarian Capital, an estimated $3.29M sold.

Based on aggregated 13F filings for Q2 2021.